DK150143C - Analogifremgangsmaade til fremstilling af indolderivater - Google Patents

Analogifremgangsmaade til fremstilling af indolderivater

Info

Publication number
DK150143C
DK150143C DK11672A DK11672A DK150143C DK 150143 C DK150143 C DK 150143C DK 11672 A DK11672 A DK 11672A DK 11672 A DK11672 A DK 11672A DK 150143 C DK150143 C DK 150143C
Authority
DK
Denmark
Prior art keywords
incidental
derivatives
preparation
analogy procedure
analogy
Prior art date
Application number
DK11672A
Other languages
Danish (da)
English (en)
Other versions
DK150143B (da
Inventor
Alan Chapman White
Robin Michael Black
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of DK150143B publication Critical patent/DK150143B/da
Application granted granted Critical
Publication of DK150143C publication Critical patent/DK150143C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DK11672A 1971-01-11 1972-01-10 Analogifremgangsmaade til fremstilling af indolderivater DK150143C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB125071 1971-01-11
GB4095971 1971-09-02
GB4095971 1971-09-02
GB5646771 1971-12-06
GB5646771 1971-12-06

Publications (2)

Publication Number Publication Date
DK150143B DK150143B (da) 1986-12-15
DK150143C true DK150143C (da) 1987-06-01

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11672A DK150143C (da) 1971-01-11 1972-01-10 Analogifremgangsmaade til fremstilling af indolderivater

Country Status (20)

Country Link
JP (1) JPS5531156B2 (enExample)
AR (1) AR192734A1 (enExample)
AT (1) AT312595B (enExample)
AU (1) AU464388B2 (enExample)
BE (1) BE777911A (enExample)
CA (1) CA1012150A (enExample)
CH (1) CH573938A5 (enExample)
CY (1) CY926A (enExample)
DK (1) DK150143C (enExample)
EG (1) EG10888A (enExample)
ES (2) ES398678A1 (enExample)
FI (1) FI54120C (enExample)
FR (1) FR2121699B1 (enExample)
GB (1) GB1366133A (enExample)
HK (1) HK52877A (enExample)
IE (1) IE35956B1 (enExample)
KE (1) KE2777A (enExample)
MY (1) MY7800048A (enExample)
NL (1) NL174251C (enExample)
SE (1) SE398645B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476740A (en) 1974-11-20 1977-06-16 Wyeth John & Brother Ltd Pyrimido-1,2-b-isoquinoline derivatives their preparation and their pharmaceutical compositions
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (ja) * 1977-06-06 1983-10-12 株式会社日立製作所 情報検索装置
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (ja) * 1984-03-28 1985-10-15 Casio Comput Co Ltd デ−タ記憶機能付小型電子機器
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
AR192734A1 (es) 1973-03-14
AT312595B (de) 1974-01-10
NL174251B (nl) 1983-12-16
FI54120C (fi) 1978-10-10
CA1012150A (en) 1977-06-14
NL174251C (nl) 1984-05-16
FI54120B (fi) 1978-06-30
NL7200415A (enExample) 1972-07-13
ES409296A1 (es) 1976-03-16
ES398678A1 (es) 1975-05-16
AU3755872A (en) 1973-07-05
MY7800048A (en) 1978-12-31
FR2121699A1 (enExample) 1972-08-25
AU464388B2 (en) 1975-08-28
IE35956B1 (en) 1976-07-07
FR2121699B1 (enExample) 1975-08-01
KE2777A (en) 1977-10-21
IE35956L (en) 1972-07-11
JPS5531156B2 (enExample) 1980-08-15
HK52877A (en) 1977-10-20
GB1366133A (en) 1974-09-11
SE398645B (sv) 1978-01-09
EG10888A (en) 1978-06-30
CY926A (en) 1977-12-23
DK150143B (da) 1986-12-15
BE777911A (fr) 1972-07-11
CH573938A5 (enExample) 1976-03-31
JPS4839500A (enExample) 1973-06-09

Similar Documents

Publication Publication Date Title
DK513578A (da) Fremgangsmaade til fremstilling af triazolylbenzopenoner
DK152050C (da) Analogifremgangsmaade til fremstilling af oxazolopyridiner
DK145676C (da) Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner
DK134316B (da) Fremgangsmåde til fremstilling af methylsubstituerede cuinoner.
DK136981B (da) Analogifremgangsmåde til fremstilling af basisk substituerede benzylphthalazon-derivater.
DK156642C (da) Analogifremgangsmaade til fremstilling af napthalenderivater
DK136215B (da) Analogifremgangsmåde til fremstilling af kinolinderivater.
DK145878C (da) Analogifremgangsmaade til fremstilling af alkylthiocyclopentanderivater
DK140985C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK147004C (da) Analogifremgangsmaade til fremstilling af oxygenerede alkylxanthinderivater
DK127119B (da) Analogifremgangsmåde til fremstilling af 6-amino-9-benzylpurin-forbindelser.
DK130212B (da) Analogifremgangsmåde til fremstilling af 7-aminoindazolderivater.
DK154295C (da) Analogifremgangsmaade til fremstilling af 2-nitroimidazol-derivater
DK132711C (da) Fremgangsmade til fremstilling af cephalosporin c
DK560675A (da) Fremgangsmade til fremstilling af thiopyrimidinderivater
DK144270C (da) Analogifremgangsmaade til fremstilling af n-carbamoyl-2-phenylethensulfonamider
DK132795C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK143847C (da) Analogifremgangsmaade til fremstilling af imidazolderivater
DK133464B (da) Analogifremgangsmåde til fremstilling af nitrosourinstofderivater.
DK132221C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK141530C (da) Analogifremgangsmaade til fremstilling af lactamer
DK139871B (da) Analogifremgangsmåde til fremstilling af 3-isonicotinoyl-benzofuranderivater.
DK132703C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK133809B (da) Analogifremgangsmåde til fremstilling af heterocycliske forbindelser.
DK145227C (da) Analogifremgangsmaade til fremstilling af 4',5-dinitro-3'-trifluormethyl-2-thiophencarboxylsyreanilid

Legal Events

Date Code Title Description
PBP Patent lapsed